Literature DB >> 15687825

Is thyroid inadequacy during gestation a risk factor for adverse pregnancy and developmental outcomes?

Stephen H LaFranchi1, James E Haddow, Joseph G Hollowell.   

Abstract

A workshop entitled, "The Impact of Maternal Thyroid Diseases on the Developing Fetus: Implications for Diagnosis, Treatment, and Screening," was held in Atlanta, Georgia, January 12-13, 2004. This paper reports on the individual session that examined thyroid inadequacy during gestation as a risk factor for adverse pregnancy and developmental outcomes. For this session the following papers were presented: "Adverse Pregnancy Outcomes"; "Thyroid Physiology in the Fetus"; "New England Data: Cretinism Revisited-Preventing Fetal Brain Damage when Mothers Have Subclinical Hypothyroidism"; "Dutch Data: Pregnancy, Maternal Thyroid (Dys)function and Outcome of the Offspring"; and "Report on the Wales Controlled Antenatal Thyroid Screening Study (CATS); A Prospective RCT." These presentations were formally discussed by invited respondents well as others in attendance. Salient points from this session about which there was agreement include the following. Maternal hypothyroidism is associated with complications of pregnancy and adverse effects on the fetus. These risks are greater in women with overt hypothyroidism compared to subclinical hypothyroidism, and also appear to be increased in women with euthyroid autoimmune thyroid disease. If maternal hypothyroidism is treated adequately, this appears to reduce the risk for adverse outcomes. The demonstration of a pattern of ontogeny of fetal cerebral cortex deiodinases and thyroid hormone receptors, beginning by 7-8 weeks' gestation, is circumstantial evidence that thyroid hormone plays an important role in fetal neurodevelopment. Significant fetal thyroid hormone production and secretion does not begin until approximately 20 weeks' gestation. If there is a significant role for thyroid hormone in fetal neurodevelopment before 20 weeks' gestation, it likely is of maternal origin. Studies demonstrate low levels of thyroxine in the fetal coelomic fluid and blood prior to 12-14 weeks' gestation. Published data consistently document a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring.

Entities:  

Mesh:

Year:  2005        PMID: 15687825     DOI: 10.1089/thy.2005.15.60

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  30 in total

1.  Polybrominated diphenyl ethers, hydroxylated polybrominated diphenyl ethers, and measures of thyroid function in second trimester pregnant women in California.

Authors:  Ami R Zota; June-Soo Park; Yunzhu Wang; Myrto Petreas; R Thomas Zoeller; Tracey J Woodruff
Journal:  Environ Sci Technol       Date:  2011-08-19       Impact factor: 9.028

2.  Luteal expression of thyroid hormone receptors during gestation and postpartum in the rat.

Authors:  Paola B Navas; Analía L Redondo; F Darío Cuello-Carrión; Laura M Vargas Roig; Susana R Valdez; Graciela A Jahn; María B Hapon
Journal:  Thyroid       Date:  2014-06       Impact factor: 6.568

Review 3.  The role of the placenta in thyroid hormone delivery to the fetus.

Authors:  Shiao Y Chan; Elisavet Vasilopoulou; Mark D Kilby
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

4.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

5.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

6.  Dichlorodiphenyltrichloroethane (DDT), DDT metabolites and pregnancy outcomes.

Authors:  Katrina L Kezios; Xinhua Liu; Piera M Cirillo; Barbara A Cohn; Olga I Kalantzi; Yunzhu Wang; Myrto X Petreas; June-Soo Park; Pam Factor-Litvak
Journal:  Reprod Toxicol       Date:  2012-11-09       Impact factor: 3.143

Review 7.  Subclinical hypothyroidism and related biochemical entities in pregnancy: implications and management.

Authors:  D S A McLeod; H D McIntyre
Journal:  Obstet Med       Date:  2010-12-03

Review 8.  Cerebral palsy.

Authors:  Michael V Johnston; Alexander H Hoon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

9.  Lipid profile and thyroid hormone status in the last trimester of pregnancy in single-humped camels (Camelus dromedarius).

Authors:  Arash Omidi; Zhila Sajedi; Mohammad Bagher Montazer Torbati; Hossein Ansari Nik
Journal:  Trop Anim Health Prod       Date:  2014-01-16       Impact factor: 1.559

Review 10.  Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants.

Authors:  Lucio G Costa; Gennaro Giordano
Journal:  Neurotoxicology       Date:  2007-08-24       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.